Cholesterol Newswire

Comprehensive Real-Time News Feed for Cholesterol.

Results 1 - 20 of 1,050 in Cholesterol

  1. Sanofi and Regeneron report positive top-line results from nine phase ...Read the original story w/Photo

    13 hrs ago | Medical News Today

    Sanofi and Regeneron Pharmaceuticals, Inc. have announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared to placebo or active comparator.

    Comment?

  2. How to manage high cholesterol levels naturally?Read the original story w/Photo

    15 hrs ago | PRWeb

    There is a growing doubt surrounding statins. Lately the debate has been rising about these cholesterol-lowering drugs.

    Comment?

  3. Antioxidant Supplements Block the Response of HDL to...Read the original story

    16 hrs ago | CiteULike

    Arteriosclerosis, Thrombosis, and Vascular Biology , Vol. 21, No. 8. , pp. 1320-1326, doi:10.1161/hq0801.095151 One strategy for treating coronary artery disease patients with low HDL cholesterol is to maximally increase the HDL-C to LDL-C ratio by combining lifestyle changes with niacin plus a statin.

    Comment?

  4. Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase 3 Trials of AlirocumabRead the original story

    Tuesday | Drugs.com

    July 30, 2014 - Sanofi and Regeneron Pharmaceuticals, Inc. today announced that nine new Phase 3 ODYSSEY trials of alirocumab in people with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared to placebo or active comparator.

    Comment?

  5. Lawsuit Funding For Lipitor and Crestor Diabetes LawsuitsRead the original story

    Yesterday | PRWeb

    ... either taking Lipitor or Crestor. Lipitor/Crestor is prescribed to people who have been diagnosed with high cholesterol. This drug contains the active ingredient atrovastatin and was marketed to patients as a means of lowering cholesterol;it has ...

    Comment?

  6. What are the health benefits of edamame?Read the original story w/Photo

    Yesterday | Medical News Today

    ... buy them shelled or in the pod, fresh or frozen. Edamame is naturally gluten-free and low calorie, contains no cholesterol and is an excellent source of protein, iron, and calcium . It is an especially important source of protein for those who ...

    Comment?

  7. BioMarin sells special FDA voucher for $67.5 millionRead the original story w/Photo

    Yesterday | Seattle Post-Intelligencer

    Regeneron Pharmaceuticals and Sanofi said Wednesday they will pay $67.5 million to BioMarin Pharmaceutical in San Rafael to acquire a voucher the companies hope will speed the approval of their experimental cholesterol drug.

    Comment?

  8. Impax manufacturing problems haunt Parkinson's drug, genericsRead the original story

    Wednesday | Business Journal

    ... to Reuters . The plant makes 12 other products that are distributed in the United States, including the generic cholesterol-fighting drug fenofibrate. An Impax spokesman said Wednesday that there have been no disruptions in manufacturing or shipping ...

    Comment?

  9. Positive Results Reported From Nine Phase III Trials of Alirocumab in HypercholesterolemiaRead the original story

    Wednesday | P&T Community

    Nine new phase III studies of alirocumab in patients with hypercholesterolemia met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol at 24 weeks compared with placebo or an active comparator.

    Comment?

  10. UPDATE 1-Sanofi, Regeneron cholesterol drug may cut heart risk, trial hintsRead the original story

    Wednesday | Reuters

    A new drug being developed by Sanofi SA and Regeneron Pharmaceuticals Inc cut cholesterol in nine late-stage clinical trials, the companies said on Wednesday, and provided the first glimpse of its potential to prevent heart attacks and strokes.

    Comment?

  11. Jim Cramer's Mad Dash: Good News for RegeneronRead the original story w/Photo

    Wednesday | TheStreet.com

    ... the stock was the focus on CNBC's "Cramer's Mad Dash" segment. The company is having a "breakthrough" with its cholesterol drug. Its other drug, Eylea, was just approved by the Food and Drug Administration following positive Phase III results, ...

    Comment?

  12. Sanofi and Regeneron Report Positive Top-Line Results from Nine Phase ...Read the original story w/Photo

    Wednesday | Applied Clinical Trials

    ... met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo or active comparator. Alirocumab is an investigational monoclonal antibody targeting ...

    Comment?

  13. Regeneron Pharmaceuticals, Inc., Sanofi (France) Drug Alirocumab Cuts ...Read the original story w/Photo

    Wednesday | BioSpace

    ... met their primary efficacy endpoint of a greater percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo or active comparator. Alirocumab is an investigational monoclonal antibody targeting ...

    Comment?

  14. New Cholesterol Drug Found to Work Better Than StatinsRead the original story

    Wednesday | News Max

    Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

    Comment?

  15. Sanofi, Regeneron drug cuts cholesterol in nine late-stage trialsRead the original story

    Wednesday | Reuters

    A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.

    Comment?

  16. Pfizer's second-quarter profit sinks 79 percent but tops forecastsRead the original story

    Tuesday | The Day

    ... dysfunction pill Viagra, the Prevnar vaccine against pneumonia and related infections, and the now-generic cholesterol fighter Lipitor, which was once the world's best-selling drug. Chairman and CEO Ian Read has been streamlining Pfizer to reduce ...

    Comment?

  17. Pfizer earnings drop less than expectedRead the original story w/Photo

    Tuesday Jul 29 | West Australian

    ... 16 percent to $1.3 billion. Revenues also rose for anti-inflammatory Celebrex and were essentially flat for anti-cholesterol drug Lipitor. But analysts noted many of Pfizer's best-sellers are on borrowed time. "The bad news is that most of these ...

    Comment?

  18. Pfizer's Q2 profit sinks 79 percent but tops forecastsRead the original story w/Photo

    Tuesday Jul 29 | The China Post

    ... dysfunction pill Viagra, the Prevnar vaccine against pneumonia and related infections, and the now-generic cholesterol fighter Lipitor, which was once the world's best-selling drug. Chairman and CEO Ian Read has been streamlining Pfizer to reduce ...

    Comment?

  19. Pfizer's 2Q profit sinks 79 pct but tops forecastsRead the original story w/Photo

    Tuesday Jul 29 | Seattle Post-Intelligencer

    ... dysfunction pill Viagra, the Prevnar vaccine against pneumonia and related infections, and the now-generic cholesterol fighter Lipitor , which was once the world's best-selling drug. Chairman and CEO Ian Read has been streamlining Pfizer to reduce ...

    Comment?

  20. Pfizer's profit sinksRead the original story w/Photo

    Tuesday Jul 29 | Iol.co.za

    ... dysfunction pill Viagra, the Prevnar vaccine against pneumonia and related infections, and the now-generic cholesterol fighter Lipitor, which was once the world's best-selling drug. That's when it divested its remaining 80 percent stake in the new ...

    Comment?